Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,161.50    22.50 (1.98%)
Bid:
1,260.00
Ask:
1,065.00
Spread: -195.00 (-15.476%)
Market Cap: £9.67b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Pre Stabilisation Notice

27 May 2026 09:31

RNS Number : 8736F
HSBC Bank plc
27 May 2026
 

27th May 2026

 

Smith & Nephew plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Smith & Nephew plc

Guarantor (if any):

n/a

Aggregate nominal amount:

EUR Benchmark

Description:

Fixed rate 12yr due 3rd Jun 2038

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

27th May 2026

Stabilisation period expected to end no later than:

3rd July 2026

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAZZGZKRNRGVZG
Date   Source Headline
15th Feb 20195:32 pmRNSTransaction in Own Shares
14th Feb 20195:37 pmRNSTransaction in Own Shares
14th Feb 20198:14 amRNSDirector Declaration
13th Feb 20195:17 pmRNSTransaction in Own Shares
12th Feb 20195:20 pmRNSTransaction in Own Shares
11th Feb 20195:41 pmRNSTransaction in Own Shares
8th Feb 20191:59 pmRNSTransaction in Own Shares
8th Feb 20199:20 amRNSDirector/PDMR Shareholding
8th Feb 20199:17 amRNSDirectorate Change
7th Feb 20197:00 amRNSFinal Results
1st Feb 20192:04 pmRNSBlock listing Interim Review
1st Feb 201912:06 pmRNSTotal Voting Rights
22nd Jan 20192:38 pmRNSSmith & Nephew acquires Ceterix Orthopaedics
16th Jan 20195:19 pmRNSDirector/PDMR Shareholding
11th Jan 20199:00 amRNSNotice of Results
7th Jan 20197:00 amRNSSmith & Nephew to present today at JP Morgan
4th Jan 20195:32 pmRNSSmith & Nephew at JP Morgan Healthcare Conference
2nd Jan 201911:19 amRNSTotal Voting Rights
18th Dec 20184:30 pmRNSAcquisition
7th Dec 201810:26 amRNSDirector/PDMR Shareholding
4th Dec 20184:20 pmRNSDirector/PDMR Shareholding
4th Dec 20184:18 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:00 pmRNSTotal Voting Rights
26th Nov 20183:07 pmRNSTransaction in Own Shares
22nd Nov 201811:57 amRNSTransaction in Own Shares
21st Nov 20185:31 pmRNSTransaction in Own Shares
20th Nov 20185:18 pmRNSTransaction in Own Shares
19th Nov 20185:49 pmRNSTransaction in Own Shares
16th Nov 20182:19 pmRNSDirector/PDMR Shareholding
16th Nov 201810:21 amRNSDirector/PDMR Shareholding
16th Nov 20188:59 amRNSTransaction in Own Shares
14th Nov 20184:46 pmRNSDirector/PDMR Shareholding
12th Nov 20183:46 pmRNSDirector/PDMR Shareholding
9th Nov 20184:26 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSDirector/PDMR Shareholding
5th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20184:26 pmRNSDirector/PDMR Shareholding
1st Nov 20183:20 pmRNSDirector/PDMR Shareholding
1st Nov 20183:00 pmRNSTotal Voting Rights
1st Nov 20187:00 amRNSTrading Statement
31st Oct 20184:00 pmRNSDirector/PDMR Shareholding
18th Oct 20183:54 pmRNSDividend Declaration
17th Oct 20187:00 amRNSNotice of Results
5th Oct 20184:36 pmRNSDirector/PDMR Shareholding
1st Oct 20181:29 pmRNSTotal Voting Rights
1st Oct 20187:00 amRNSNotice of Results
19th Sep 20188:48 amRNSDirector/PDMR Shareholding
3rd Sep 20181:23 pmRNSTotal Voting Rights
23rd Aug 20184:42 pmRNSDirector/PDMR Shareholding
16th Aug 20182:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.